Fontan Physiology Ventilation Strategy

Sponsor
University of Pittsburgh (Other)
Overall Status
Recruiting
CT.gov ID
NCT04672538
Collaborator
(none)
30
1
2
19
1.6

Study Details

Study Description

Brief Summary

This study will investigate the different tidal volume (Vt) strategies during a cardiac catheterization procedure to determine whether or not low or high Vt have an impact on cardiac output.

Research question: While maintaining the same minute ventilation/PaCO2, does higher Vt (10 cc/kg)/lower rate vs. lower Vt (6 cc/kg)/higher rate (maintaining consistent PEEP) result in improved cardiac output?

Condition or Disease Intervention/Treatment Phase
  • Procedure: Low Vt protocol
  • Procedure: High Vt protocol
N/A

Detailed Description

The trial will be a randomized crossover design. The study cohort will be randomized (50/50) to begin with either low Vt or high Vt ventilation. After achieving steady state, initial cardiac output measurements will be made using a measured oxygen consumption (VO2) and the Fick principle, per routine clinical protocol. Following baseline assessment of cardiac output and hemodynamics (which is standard of care for all catheterization procedures), participants will be transitioned to the alternative ventilation modality (high Vt or low Vt). After a 5-minute equilibration period, oxygen saturations and VO2 measurements will be re-acquired, to determine cardiac output and hemodynamics in this second state.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
The trial will be a randomized crossover design.The trial will be a randomized crossover design.
Masking:
None (Open Label)
Masking Description:
Randomized cross over
Primary Purpose:
Supportive Care
Official Title:
Impact of Fontan Ventilation Strategy on Cardiac Output: An Invasive Physiologic Cross-over Study
Actual Study Start Date :
Mar 2, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Low transition to High Vt protocol

This arm of the study will begin with lower tidal volumes at higher respiratory rates for initial hemodynamic measurements. They will then be transitioned to the higher tidal volume at lower respiratory rate condition for repeat hemodynamic measurement.

Procedure: Low Vt protocol
Low Vt protocol - tidal volumes (Vt) 6 ml/kg, respiratory rate required for end tidal carbon dioxide (EtCO2) of 36-38 mmHg, PEEP 5 centimeter of water (cm-H20) , I:E ratio 1:2

Procedure: High Vt protocol
High Vt protocol - tidal volumes (Vt) 10 ml/kg, respiratory rate required for EtCO2 of 36-38 mm Hg, PEEP 5 cmH2O, I:E ratio 1:3.

Experimental: High transition to Low Vt protocol

This arm of the study will begin with higher tidal volumes at lower respiratory rates for initial hemodynamic measurements. They will then be transitioned to the lower tidal volume at higher respiratory rate condition for repeat hemodynamic measurement.

Procedure: Low Vt protocol
Low Vt protocol - tidal volumes (Vt) 6 ml/kg, respiratory rate required for end tidal carbon dioxide (EtCO2) of 36-38 mmHg, PEEP 5 centimeter of water (cm-H20) , I:E ratio 1:2

Procedure: High Vt protocol
High Vt protocol - tidal volumes (Vt) 10 ml/kg, respiratory rate required for EtCO2 of 36-38 mm Hg, PEEP 5 cmH2O, I:E ratio 1:3.

Outcome Measures

Primary Outcome Measures

  1. Cardiac Output [Measurements will occur at the 5-minute equilibration period into the ventilation strategy.]

    The investigators will assess cardiac output using the Fink principle for each arm of randomization.

Secondary Outcome Measures

  1. Pulmonary blood flow [Measurements will occur at the 5-minute equilibration period into the ventilation strategy.]

    The investigators will compare blood flow in both arms.

  2. Systemic blood pressure [Measurements will occur at the 5-minute equilibration period into the ventilation strategy.]

    The investigators will assess the vital sign in both intervention arms.

  3. Pulmonary arterial pressure [Measurements will occur at the 5-minute equilibration period into the ventilation strategy.]

    The investigators will assess pressures in both intervention arms.

  4. Pulmonary vascular resistance [Measurements will occur at the 5-minute equilibration period into the ventilation strategy.]

    Completed using pulmonary vascular resistance (PVR) equation from measurements obtained during the cardiac catheterization.

  5. Systemic vascular resistance [Measurements will occur at the 5-minute equilibration period into the ventilation strategy.]

    This will be calculated using appropriate equations using measurement obtained during catheterization procedure.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients of UPMC Children's Hospital of Pittsburgh that have Fontan physiology (single heart ventricle) that are presenting as outpatients to undergo a cardiac catheterization with general endotracheal anesthesia for purpose of diagnosis or interventional cath.

  • Parents and/or guardians willing to provide informed consent.

Exclusion Criteria:
  • Those unwilling to give consent and those patients who do not have Fontan physiology.

  • Any urgent/emergent catheterization procedure will be excluded.

  • Any Fontan patient having a cardiac catheterization under monitored anesthesia care (as opposed to general endotracheal anesthesia) will not be eligible.

  • Inability to undergo cardiac catheterization.

  • Pregnant women will be excluded.

  • < 6 weeks post-op from Fontan completion surgery

  • Same hospitalization as Fontan completion surgery

  • Intrinsic pulmonary disease which would be anticipated to impact study protocol / findings

  • Fontan completion surgery performed at age > 7 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania United States 15224

Sponsors and Collaborators

  • University of Pittsburgh

Investigators

  • Principal Investigator: Phillip S Adams, DO, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Phillip S. Adams, DO, Assistant Professor of Anesthesiology, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04672538
Other Study ID Numbers:
  • STUDY20100012
First Posted:
Dec 17, 2020
Last Update Posted:
Mar 8, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 8, 2022